Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib with Platinum-based Chemo in TNBC/gBRCA Breast Cancer
NCT03150576Phase 3Recruiting
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2016
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olaparib in breast cancer, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started May 2016; status: recruiting.
02
Drugs
olaparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03150576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150576.